| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancements in combining targeted therapy and immunotherapy for colorectal cancer
|
Singh, Manisha
|
|
|
10 |
7 |
p. 598-609
|
artikel
|
| 2 |
Advisory Board and Contents
|
|
|
|
10 |
7 |
p. i-ii
|
artikel
|
| 3 |
A new BRAF inhibitor breaks resistance barriers
|
Scotece, Morena
|
|
|
10 |
7 |
p. 576-578
|
artikel
|
| 4 |
B7-H3: a robust target for immunotherapy in prostate cancer
|
Pulido, Rafael
|
|
|
10 |
7 |
p. 584-587
|
artikel
|
| 5 |
COX2-dependent suppression of anticancer immunity
|
Lira, María Cecilia
|
|
|
10 |
7 |
p. 573-575
|
artikel
|
| 6 |
Engineered bacterial therapeutics for detecting and treating CRC
|
Siguenza, Nicole
|
|
|
10 |
7 |
p. 588-597
|
artikel
|
| 7 |
Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development
|
Yasuda, Tadahito
|
|
|
10 |
7 |
p. 627-642
|
artikel
|
| 8 |
Immunometabolism of CD8+ T cell differentiation in cancer
|
Shi, Hao
|
|
|
10 |
7 |
p. 610-626
|
artikel
|
| 9 |
Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer
|
Abbosh, Chris
|
|
|
10 |
7 |
p. 643-654
|
artikel
|
| 10 |
NETscape or NEThance: tailoring anti-cancer therapy
|
Mousset, Alexandra
|
|
|
10 |
7 |
p. 655-667
|
artikel
|
| 11 |
Subscription & copyright page
|
|
|
|
10 |
7 |
p. e1
|
artikel
|
| 12 |
The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulations
|
Hadfield, Matthew J.
|
|
|
10 |
7 |
p. 579-583
|
artikel
|
Tijdschrift beschrijving